Simon C. Lowry's most recent trade in Emergent Biosolutions Inc was a trade of 3,543 Common Stock done at an average price of $11.4 . Disclosure was reported to the exchange on Dec. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc | Simon C. Lowry | SVP, R&D, CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.41 per share. | 14 Dec 2025 | 3,543 | 88,439 (0%) | 0% | 11.4 | 40,426 | Common Stock |
| Emergent Biosolutions Inc | Simon C. Lowry | SVP, R&D, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 102,999 | - | - | Employee Stock Options (Right to Buy) | |
| Emergent Biosolutions Inc | Simon C. Lowry | SVP, R&D, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 62,500 | 91,982 (0%) | 0% | 0 | Common Stock | |
| Emergent Biosolutions Inc | Simon C. Lowry | SVP, R&D, CMO | 15 Dec 2024 | 40,499 | 40,499 | - | - | Employee Stock Option (Right to buy) | ||
| Emergent Biosolutions Inc | Simon C. Lowry | SVP, R&D, CMO | 15 Dec 2024 | 29,482 | 29,482 (0%) | 0% | 0 | Common Stock |